staurosporine aglycone has been researched along with Lymphoma, Non-Hodgkin in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sniderhan, LF | 1 |
| Garcia-Bates, TM | 1 |
| Burgart, M | 1 |
| Bernstein, SH | 1 |
| Phipps, RP | 1 |
| Maggirwar, SB | 1 |
1 other study available for staurosporine aglycone and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.
Topics: Apoptosis; Autocrine Communication; B-Lymphocytes; Brain-Derived Neurotrophic Factor; Carbazoles; Ce | 2009 |